ELK2BP

Across TCGA pan-cancer cohorts, ELK2BP RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated ELK2BP data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher ELK2BP RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ELK2BP expression acts as an unfavorable survival marker, although some lineages such as LGG and BRCA show a favorable association.

LGG, BRCA, and CHOL are the cancer types where ELK2BP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Tertile	All	0.565	0.283	<.001	43	view →
BRCA	DFS	Median	III,IV	0.935	0.826	.001	42	view →
CHOL	OS	Tertile	III,IV	0.136	0.859	.003	36	view →
DLBC	DFS	Median	All	0.637	0.913	.003	29	view →
COAD	OS	Tertile	IV	0.089	0.676	<.001	27	view →
KIRP	DFS	Tertile	All	0.757	0.929	.004	18	view →
GBM	DFS	Tertile	All	0.328	0.219	.013	15	view →
TGCT	DFS	Tertile	III,IV	0.505	1.000	.044	12	view →
KICH	DFS	Tertile	III,IV	0.043	0.897	.045	9	view →
THCA	OS	Quartile	III,IV	0.788	0.948	.015	9	view →
SARC	DFS	Quartile	All	0.768	0.572	.005	9	view →
STAD	DFS	Median	All	0.622	0.780	.017	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

ELK2BP–LGG (DFS)

Open the LGG breakdown →